NCT05074732 Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
| NCT ID | NCT05074732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Health Service Executive, Ireland |
| Condition | Schizophrenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2019-12-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2019-12-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The DUNDRUM Forensic Redevelopment Evaluation study (D-FOREST study) is a multi-site comprehensive evaluation of a complete National Forensic Mental Health Service. The study will have a prospective, observational, longitudinal design which will permit the evaluation of benefit over time for individual patients, groups of patients and the evaluation of the benefit in terms of service based outcomes of the redevelopment of a complete National Forensic Mental Health Service e.g. effects on waiting list times, length of stay. The study will systematically evaluate multiple domains of recovery in a complete National Forensic Service, including patients' physical health, mental health, offending behaviours and social and occupational functioning.
Eligibility Criteria
Inclusion Criteria: * Admitted to the National Forensic Mental Health Service (NFMHS) Ireland after 1st December 2019 until 7 years after the transfer of the National Service to the newly developed complete National Forensic Service at Portrane, North Dublin, Ireland. Exclusion Criteria: * This study comprises a complete cohort of admissions to the NFMHS. All adult patients admitted during the time period will be included in the study, regardless of their length of stay.
Contact & Investigator
Mary Davoren, M.D.
PRINCIPAL INVESTIGATOR
Trinity College University of Dublin
Frequently Asked Questions
Who can join the NCT05074732 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Schizophrenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05074732 currently recruiting?
Yes, NCT05074732 is actively recruiting participants. Contact the research team at davorem@tcd.ie for enrollment information.
Where is the NCT05074732 trial being conducted?
This trial is being conducted at Dublin, Ireland.
Who is sponsoring the NCT05074732 clinical trial?
NCT05074732 is sponsored by Health Service Executive, Ireland. The principal investigator is Mary Davoren, M.D. at Trinity College University of Dublin. The trial plans to enroll 350 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.